[1]曹雯 孙洪平 范尧夫 胡咏新 郑仁东 王昆.2型糖尿病患者血尿酸水平与胰岛素抵抗的 相关性分析[J].国际内分泌代谢杂志,2020,40(03):145-149.[doi:10.3760/cma.j.issn.1673-4157.2020.03.001]
　Cao Wen,Sun Hongping,Fan Yaofu,et al.Correlation analysis of serum uric acid with insulin resistance in type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2020,40(03):145-149.[doi:10.3760/cma.j.issn.1673-4157.2020.03.001]
点击复制

2型糖尿病患者血尿酸水平与胰岛素抵抗的 相关性分析()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
40
期数:
2020年03期
页码:
145-149
栏目:
论著
出版日期:
2020-05-20

文章信息/Info

Title:
Correlation analysis of serum uric acid with insulin resistance in type 2 diabetic patients
作者:
曹雯1 孙洪平2 范尧夫2 胡咏新2 郑仁东2 王昆1
1南京医科大学附属江宁医院内分泌科 211100; 2南京中医药大学附属中西医结合医院内分泌院区 210028
Author(s):
Cao Wen1;  Sun Hongping2;  Fan Yaofu2;  Hu Yongxin2;  Zheng Rendong2;  Wang Kun1.
1Department of Endocrinology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China; 2Endocrine and Diabetes Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
关键词:
2型糖尿病;  血尿酸;  胰岛素抵抗;  体重指数
Keywords:
Type 2 diabetes mellitus;  Blood uric acid;  Insulin resistance;  Body mass index
DOI:
10.3760/cma.j.issn.1673-4157.2020.03.001
摘要:
目的 探讨2型糖尿病患者血尿酸水平与胰岛素抵抗的相关性。方法 纳入2015年1月至2017年12月在南京中医药大学附属中西医结合医院内分泌科住院的208例2型糖尿病患者,根据体重指数分为体重正常组(体重指数<25 kg/m2)、超重组(25 kg/m2≤体重指数<28 kg/m2)、肥胖组(体重指数≥28 kg/m2),测定血尿酸、总胆固醇、甘油三酯、低密度脂蛋白-胆固醇(LDL-C)、空腹血糖、餐后血糖、HbA1c、空腹胰岛素(FINS)水平,并计算稳态模型评估-胰岛素抵抗指数(HOMA-IR),比较各指标的组间差异。根据HbA1c是否大于7%分为达标组和未达标组,根据HOMA-IR和血尿酸水平采用四分位法再分为亚组(Q1～Q4),比较各亚组指标之间的差异。对血尿酸水平与血糖、HbA1c、血脂、胰岛素等进行相关性分析,并做线性回归分析。结果 与体重正常组相比,超重组与肥胖组血尿酸、HOMA-IR、空腹血糖、餐后血糖、HbA1c、甘油三酯、LDL-C、FINS水平逐渐上升(F=0.911～36.668,P均<0.05); HbA1c未达标组血尿酸、空腹血糖和餐后血糖水平明显高于HbA1c达标组(t=1.444、2.204、2.083,P均<0.05); 从Q1组到Q4组,随着HOMA-IR的升高,血尿酸、体重指数、空腹血糖、甘油三酯水平逐渐上升(F=2.867、29.625、30.398、17.134,P均<0.05)。从Q1组到Q4组,伴随血尿酸水平升高,体重指数、空腹血糖、餐后血糖、甘油三酯、FINS水平上升(F=9.428、8.707、12.409、39.010,P均<0.05)。血尿酸水平与空腹血糖(r=0.186,P=0.008)、餐后血糖(r=0.234,P=0.009)、HbA1c(r=0.183,P=0.009)、甘油三酯(r=0.449,P<0.001)、FINS(r=0.259,P<0.001)、体重指数(r=0.239,P=0.001)、HOMA-IR(r=0.161,P=0.022)呈正相关。线性回归分析提示甘油三酯(T=3.195,95% CI: 4.213～17.806,P<0.05)、体重指数(T=2.793,95% CI: 1.172～6.805,P<0.05)、HbA1c(T=2.320,95% CI: 0.693～8.542,P<0.05)是2型糖尿病患者发生血尿酸水平升高的危险因素。结论 2型糖尿病患者血尿酸水平升高与肥胖、糖脂代谢异常导致的胰岛素抵抗增加有关。
Abstract:
Objective To investigate the correlation between serum level of uric acid(SUA)and insulin resistance in type 2 diabetic patients.Methods A total of 208 patients with type 2 diabetes who were admitted to the Department of Endocrinology, the Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine from January 2015 to December 2017 were included. All patients were divided into normal body weight group[body mass index(BMI)<25 kg/m2], over weight group(25 kg/m2≤BMI<28 kg/m2)and obesity group(BMI≥28 kg/m2)according to BMI. The SUA, total cholesterol, triglycerides(TG), low density lipoprotein-cholesterol(LDL-C), fasting blood glucose(FBG), postprandial blood glucose(PBG), HbA1c, and fasting insulin(FINS)level were measured. The homeostasis model assessment of insulin resistance(HOMA-IR)was also calculated. Differences among groups were compared. And according to whether their HbA1c was more than 7%, patients were divided into HbA1c-target-achieved group and HbA1c-target-not-achieved group. Then patients were further divided into 4 groups(Q1-Q4)according to the quartiles of HOMA-IR and SUA. Correlation between SUA and blood glucose, HbA1c, blood lipids, insulin and other indicators was analyzed, and linear regression analysis was also used.Results Compared with normal body weight group, the levels of SUA, HOMA-IR, FBG, PBG, HbA1c, TG, LDL-C and FINS were increased(F=0.911-36.668, all P<0.05). SUA, FBG and PBG in HbA1c-target-not-achieved group were significantly higher than those of the HbA1c-target-achieved group(t=1.444, 2.204, 2.083, all P<0.05). From Q1 group to Q4 group, with the increase of HOMA-IR, the level of SUA, BMI, FBG and TG were gradually increased(F=2.867, 29.625, 30.398, 17.134, all P<0.05). From Q1 group to Q4 group, with the increase of SUA, the level of BMI, FBG, PBG, TG and FINS level were increased(F=9.428,8.707,12.409,39.010, all P<0.05). The level of SUA was positively correlated with FBG(r=0.186, P=0.008), PBG(r=0.234, P=0.009), HbA1c(r=0.183, P=0.009), TG(r=0.449, P<0.001), FINS(r=0.259, P<0.001), BMI(r=0.239, P=0.001)and HOMA-IR(r=0.161, P=0.022). Linear regression analysis suggested that TG(T=3.195, 95% CI: 4.213-17.806, P<0.05), BMI(T=2.793, 95% CI: 1.172-6.805, P<0.05)and HbA1c(T=2.320, 95% CI: 0.693-8.542, P<0.05)were risk factors for the increase of SUA in patients with type 2 diabetes mellitus.Conclusion The increase of SUA in type 2 diabetes mellitus is associated with increased insulin resistance caused by obesity and abnormal glucose and lipid metabolism.

参考文献/References:

[1] Rehman K,Akash MSH,Liaqat A,et al.Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus[J].Crit Rev Eukaryot Gene Expr,2017,27(3):229-236.DOI:10.1615/CritRevEukaryotGeneExpr.2017019712.
[2] Yi XL,Li J,Meng DM,et al.An intron variant of SLC2A9 increases the risk for type 2 diabetes mellitus complicated with hyperuricemia in Chinese male population[J].Iran J Public Health,2018,47(6):844-851.
[3] Aksenov S,Peck CC,Eriksson UG,et al. Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics[J].Physiol Rep,2018,6(5). DOI:10.14814/phy2.13614.
[4] Gobusamang E,Nyepetsi NG,Motswaledi MS,et al.Hyperuricaemia is associated with dyslipidemia but not HbA1c among type 2 diabetes mellitus patients in Botswana[J].Afr J Lab Med,2019,8(1):786.DOI:10.4102/ajlm.v8i1.786.
[5] Xiong Q,Liu J,Xu Y.Effects of uric acid on diabetes mellitus and its chronic complications[J].Int J Endocrinol,2019,2019:9691345. DOI:10.1155/2019/9691345.
[6] 程炳菲,牟泽芃,王颜刚.男性2型糖尿病血尿酸与胰岛素抵抗及肥胖的关系[J].青岛大学学报(医学版),2018,54(3):287-290.DOI:10.11712/jms201803008.
[7] Mele C,Tagliaferri MA,Saraceno G,et al.Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals[J].Nutr Metab Cardiovasc Dis,2018,28(10):1029-1035.DOI:10.1016/j.numecd.2018.06.010.
[8] Hussain A,Latiwesh OB,Ali F,et al.Effects of body mass index, glycemic control,and hypoglycemic drugs on serum rric acid levels in type 2 diabetic patients[J].Cureus,2018,10(8):e3158.DOI:10.7759/cureus.3158.
[9] Lin LY,Hsu CY,Lee HA,et al.Gender difference in the association of dietary patterns and metabolic parameters with obesity in young and middle-aged adults with dyslipidemia and abnormal fasting plasma glucose in Taiwan[J].Nutr J,2019,18(1):75. DOI:10.1186/s12937-019-0503-x.
[10] Leyva F,Wingrove CS,Godsland IF,et al.The glycolytic pathway to coronary heart disease: a hypothesis[J].Metabolism,1998,47(6):657-662. DOI:10.1016/s0026-0495(98)90026-9.
[11] Tsunoda S,Kamide K,Minami J,et al.Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent[J].Am J Hypertens,2002,15(8):697-701. DOI:10.1016/s0895-7061(02)02953-9.
[12] Cui Y,Bu H,Ma X,et al.The relation between serum uric acid and HbA1c is dependent upon hyperinsulinemia in patients with newly diagnosed type 2 diabetes mellitus[J].J Diabetes Res,2016,2016:7184123.DOI:10.1155/2016/7184123.
[13] Kim OK,Jun W,Lee J.Mechanism of ER stress and inflammation for hepatic insulin resistance in obesity[J].Ann Nutr Metab,2015,67(4):218-227.DOI:10.1159/000440905.
[14] Wan X,Xu C,Lin Y,et al.Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism[J].J Hepatol,2016,64(4):925-932. DOI:10.1016/j.jhep.2015.11.022.
[15] Obeidat AA,Ahmad MN,Haddad FH,et al. Leptin and uric acid as predictors of metabolic syndrome in Jordanian adults[J].Nutr Res Pract,2016,10(4):411-417.DOI: 10.4162/nrp.2016.10.4.411.
[16] Perez-Ruiz F,Aniel-Quiroga MA,Herrero-Beites AM,et al. Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients[J].Rheumatol Int,2015,35(9):1519-1524.DOI:10.1007/s00296-015-3242-0.
[17] Li C,Hsieh MC,Chang SJ.Metabolic syndrome,diabetes,and hyperuricemia[J].Curr Opin Rheumatol,2013,25(2):210-216.DOI:10.1097/BOR.0b013e32835d951e.
[18] Fu S,Yao Y,Zhao Y,et al.Relationships of hyperhomocysteinemia and hyperuricemia with metabolic syndrome and renal function in Chinese centenarians[J].Front Endocrinol(Lausanne),2018,9:502.DOI:10.3389/fendo.2018.00502.

相似文献/References:

[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
　Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
　Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
　Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
　Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
　Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
　Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
　Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(03):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
　Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(03):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]

备注/Memo

备注/Memo:
通信作者:郑仁东,Email:zhrd2000@sina.com; 王昆,Email:goldinnanjing@163.com
基金项目:江苏省中医药局项目(FY201808); 江苏省卫计委课题项目(BJ17029)
Corresponding author: Zheng Rendong, Email:zhrd2000@sina.com; Wang Kun, Email:goldinnanjing@163.com
Fund program:Jiangsu Province Chinese Medicine Bureau Science and Technology Project(FY201808); Jiangsu Provincial Health and Family Planning Commission Project(BJ17029)
更新日期/Last Update: 2020-05-20